Metabolomics Market, By Indication (Cancer, Neurological Disorders, Inborn Errors Of Metabolism, Cardiovascular Disorders, Others), And By Region (North America, Europe, Asia Pacific, Middle East & Africa, South America) – Market Size & Forecasting To 2028

The Metabolomics Market report points out national and global business prospects and competitive conditions for metabolomics. Market size estimation and forecasts were given based on a detailed research methodology tailored to the conditions of the demand for metabolomics. The metabolomics market has been segmented by indication (cancer, neurological disorders, inborn errors of metabolism, cardiovascular disorders, others). Historical background for the demand of metabolomics has been studied according to organic and inorganic innovations in order to provide accurate estimates of the market size. Primary factors influencing the growth of the demand metabolomics have also been established with potential gravity. Major regions covered in the study include North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Market Segmentation:

By Indication:   

  • Cancer
  • Neurological Disorders
  • Inborn Errors of Metabolism
  • Cardiovascular Disorders
  • Others

By Region:

North America Metabolomics Market

  • North America, by Country
    • US
    • Canada
    • Mexico
  • North America, by Indication

Europe Metabolomics Market

  • Europe, by Country
    • Germany
    • Russia
    • UK
    • France
    • Italy
    • Spain
    • The Netherlands
    • Rest of Europe 
  • Europe, by Indication

Asia Pacific Metabolomics Market

  • Asia Pacific, by Country
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Rest of Asia Pacific 
  • Asia Pacific, by Indication

Middle East & Africa Metabolomics Market

  • Middle East & Africa, by Country 
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East & Africa
  • Middle East & Africa, by Indication

South America Metabolomics Market

  • South America, by Country 
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • South America, by Indication

Major Companies: Agilent Technologies, Inc., Bio- Rad Laboratories, Inc., Bruker Corporation, Danaher Corporation, Thermo Fisher Scientific, Inc., Waters Corporation, Shimadzu Corporation, LECO Corporation, Biocrates Life Sciences AG, Metabolon, Inc., and Human Metabolome Technologies, Inc.

Years Covered in the Study:

Historic Year: 2017-2018

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2028

Objectives of this report:

  • To estimate market size for metabolomics market on regional and global basis.
  • To identify major segments in metabolomics market and evaluate their market shares and demand.
  • To provide a competitive scenario for the metabolomics market with major developments observed by key companies in the historic years.
  • To evaluate key factors governing the dynamics of metabolomics market with their potential gravity during the forecast period.

Reasons to Buy This Report:

  • Provides niche insights for decision about every possible segment helping in strategic decision making process.
  • Market size estimation of the metabolomics market on a regional and global basis.
  • A unique research design for market size estimation and forecast.
  • Identification of major companies operating in the market with related developments
  • Exhaustive scope to cover all the possible segments helping every stakeholder in the metabolomics

Customization:

This study is customized to meet your specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country
  • Product Specific Competitive Analysis

For more information, contact: sales@quincemarketinsights.com